| 11.03 0.5 (4.75%) | 06-11 16:00 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | ||||
| Targets | 6-month : | 14.47 |
1-year : | 16.9 |
| Resists | First : | 12.39 |
Second : | 14.47 |
| Pivot price | 10.29 |
|||
| Supports | First : | 10.35 |
Second : | 9.09 |
| MAs | MA(5) : | 10.51 |
MA(20) : | 10.16 |
| MA(100) : | 11.78 |
MA(250) : | 11.18 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 89.3 |
D(3) : | 80.5 |
| RSI | RSI(14): 57.5 |
|||
| 52-week | High : | 14.56 | Low : | 6.76 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ VREX ] has closed It is unclear right now based on current values. 43.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 10.78 - 10.84 | 10.84 - 10.89 |
| Low: | 10.35 - 10.41 | 10.41 - 10.47 |
| Close: | 10.43 - 10.53 | 10.53 - 10.63 |
Varex Imaging Corporation (VREX) specializes in the development and production of X-ray imaging components. Its operations are divided into two primary divisions: Medical and Industrial. Within the Medical segment, Varex provides a comprehensive range of X-ray imaging components. These include essential hardware like X-ray tubes, digital detectors, and high-voltage connectors, alongside sophisticated software solutions for image processing, 3D reconstruction, and computer-aided diagnostics. The segment also supplies critical ancillary devices such as collimators, generators, and automatic exposure control mechanisms. These medical products serve a wide spectrum of applications, from general diagnostic imaging like radiography and fluoroscopy, to specialized areas such as mammography, computed tomography (CT), cardiac procedures, dental imaging, and surgical applications. They are also vital for radiation therapy, oncology, and advanced computer-aided detection systems. The Industrial segment focuses on providing X-ray technology for security and industrial inspection. Its offerings include Linatron X-ray accelerators, X-ray tubes, digital detectors, and high-voltage connectors. These components are crucial for diverse applications such as airport security scanning, cargo screening at border crossings, and nondestructive testing across various industries. Varex distributes its products through multiple channels, including direct sales to end-users, partnerships with imaging system Original Equipment Manufacturers (OEMs), independent service providers, and a network of distributors. With a significant global footprint, the company maintains operations across North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Established in 2016, Varex Imaging Corporation is headquartered in Salt Lake City, Utah.
Mon, 08 Jun 2026
Wall Street Analysts See a 78.39% Upside in VAREX IMAGING (VREX): Can the Stock Really Move This High? - Yahoo Finance
Sun, 07 Jun 2026
(VREX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Wed, 03 Jun 2026
Is VAREX IMAGING (VREX) a Great Value Stock Right Now? - Yahoo Finance
Mon, 18 May 2026
Should Value Investors Buy VAREX IMAGING (VREX) Stock? - Yahoo Finance
Mon, 11 May 2026
Varex Imaging Corporation Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts - Yahoo Finance
Thu, 07 May 2026
Varex Imaging (NASDAQ: VREX) swings to loss as refinancing and inventory build hit cash - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 42 (M) |
| Shares Float | 41 (M) |
| Held by Insiders | 1.6 (%) |
| Held by Institutions | 101.2 (%) |
| Shares Short | 1,290 (K) |
| Shares Short P.Month | 1,380 (K) |
| EPS | -2 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 11.38 |
| Profit Margin | -9.7 % |
| Operating Margin | 6.6 % |
| Return on Assets (ttm) | 3.2 % |
| Return on Equity (ttm) | -15.7 % |
| Qtrly Rev. Growth | 1.5 % |
| Gross Profit (p.s.) | 6.82 |
| Sales Per Share | 20.34 |
| EBITDA (p.s.) | 2.12 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -2 (M) |
| Levered Free Cash Flow | -40 (M) |
| PE Ratio | -5.52 |
| PEG Ratio | 4.9 |
| Price to Book value | 0.96 |
| Price to Sales | 0.54 |
| Price to Cash Flow | -232.46 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |